Challenges in glioblastoma research: focus on the tumor microenvironment
Glioblastoma (GBM) is the most deadly type of malignant brain tumor, despite extensive
molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has …
molecular analyses of GBM cells. In recent years, the tumor microenvironment (TME) has …
Immune checkpoint inhibitors in human glioma microenvironment
A Ghouzlani, S Kandoussi, M Tall, KP Reddy… - Frontiers in …, 2021 - frontiersin.org
Gliomas are the most common primary brain tumors in adults. Despite the fact that they are
relatively rare, they cause significant morbidity and mortality. High-grade gliomas or …
relatively rare, they cause significant morbidity and mortality. High-grade gliomas or …
The endocannabinoid system: A target for cancer treatment
In recent years, the endocannabinoid system has received great interest as a potential
therapeutic target in numerous pathological conditions. Cannabinoids have shown an …
therapeutic target in numerous pathological conditions. Cannabinoids have shown an …
Targeting RTK-PI3K-mTOR axis in gliomas: An update
M Colardo, M Segatto, S Di Bartolomeo - International Journal of …, 2021 - mdpi.com
Gliomas are the most common and challenging malignancies of the central nervous system
(CNS), due to their infiltrative nature, tendency to recurrence, and poor response to …
(CNS), due to their infiltrative nature, tendency to recurrence, and poor response to …
Patient-derived glioma models: from patients to dish to animals
Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults
associated with a poor survival. Current standard of care consists of surgical resection …
associated with a poor survival. Current standard of care consists of surgical resection …
Glioblastoma microenvironment and invasiveness: new insights and therapeutic targets
Glioblastoma (GBM) is the most common and malignant primary brain cancer in adults.
Without treatment the mean patient survival is approximately 6 months, which can be …
Without treatment the mean patient survival is approximately 6 months, which can be …
From cells to organoids: The evolution of blood-brain barrier technology for modelling drug delivery in brain cancer
E Gonzales-Aloy, A Ahmed-Cox, M Tsoli… - Advanced Drug Delivery …, 2023 - Elsevier
Brain cancer remains the deadliest cancer. The blood–brain barrier (BBB) is impenetrable to
most drugs and is a complex 3D network of multiple cell types including endothelial cells …
most drugs and is a complex 3D network of multiple cell types including endothelial cells …
In vitro glioblastoma models: A journey into the third dimension
M Paolillo, S Comincini, S Schinelli - Cancers, 2021 - mdpi.com
Simple Summary In this review, the thorny issue of glioblastoma models is addressed, with a
focus on 3D in vitro models. In the first part of the manuscript, glioblastoma features and …
focus on 3D in vitro models. In the first part of the manuscript, glioblastoma features and …
Cannabinoids in glioblastoma therapy: new applications for old drugs
CA Dumitru, IE Sandalcioglu, M Karsak - Frontiers in molecular …, 2018 - frontiersin.org
Glioblastoma (GBM) is the most malignant brain tumor and one of the deadliest types of
solid cancer overall. Despite aggressive therapeutic approaches consisting of maximum …
solid cancer overall. Despite aggressive therapeutic approaches consisting of maximum …
Engineering three-dimensional tumor models to study glioma cancer stem cells and tumor microenvironment
H Ruiz-Garcia, K Alvarado-Estrada… - Frontiers in Cellular …, 2020 - frontiersin.org
Glioblastoma (GBM) is the most common and devastating primary brain tumor, leading to a
uniform fatality after diagnosis. A major difficulty in eradicating GBM is the presence of …
uniform fatality after diagnosis. A major difficulty in eradicating GBM is the presence of …